Clinical Trials Insight: 700023568

Trial Profile

Clinical Trials Insight: 700023568

Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs BGC 201259 (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors BTG
  • Most Recent Events

    • 02 Apr 2009 Status changed from planning to discontinued, as reported in BTG media release.
    • 19 May 2008 According to BTG media release trial scheduled to start in the second half of 2008.
    • 13 Nov 2007 Endpoints added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top